Ventyx Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Ventyx Biosciences

11/05/2023 22:01

* Ventyx Biosciences Inc  VTYX.OQ  reported a quarterly
adjusted
loss of 68 cents​​ per share for the quarter ended in March. The
mean expectation of nine analysts for the quarter was for a loss
of 65 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Ventyx Biosciences Inc's reported EPS for the quarter was
a loss
of 68 cents​.
    * The mean earnings estimate of analysts had fallen by
about 9.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Ventyx Biosciences Inc shares had risen by 17.9% this
quarter and gained 20.5% so far this year.
    * The company reported a quarterly loss of $38.93 million.
    * Wall Street's median 12-month price target for Ventyx
Biosciences Inc is $55.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.65          -0.68          Missed
 Dec. 31 2022      -0.64          -0.62          Beat
 Sep. 30 2022      -0.44          -0.59          Missed
 Jun. 30 2022      -0.45          -0.39          Beat